His own bitter experiences to get research literature prompted him to begin an initiative that would free the scientific knowledge from all barriers. Dr Gedela got young scientist award from Human Proteome Organization at Seoul, Korea in 2007, where he explored the difficulties faced by scholars from developing countries to access the scientific literature, with their support he started first open access journal called Journal of proteomics & Bioinformatics.
Encouraged by his fellow scientist friends and scholars at Andhra University and Stanford University, Dr. Gedela started Omics International Pvt Ltd to make healthcare and scientific information open access. As Dr. Gedela’s initial interests were in the field of proteomics and diabetes he named his organization as ‘omics’. As he was well aware of the difficulties of his fellow scientists in accessing the instant information and knowledge, he committed himself to the mission of ‘Open Access’ to guarantee free and immediate access to information for any academic or research requirement. As of now Omics International is operating in six Special Economic Zone Units with 3000+ employees at Hyderabad, Chennai and Delhi. As part of expansion Omics International Pvt Ltd acquired several small and medium size companies in publishing and events sector. These companies are majorly from Europe, Canada and United States and ru.
Today, Omics International Pvt Ltd is an ever expanding publishing group which publishes 700 scientific and healthcare journals in the fields of Clinical, Medical, Engineering & Technology, Management, and Life Sciences that publishes 50,000 scientific research articles annually. Not confining to publishing alone, Dr. Gedela quickly expanded his activates to International Conferences and events. With more than 3000+ Global Annual Medical and Scientific Meetings in 40 countries, Omics International meetings are dais for 60,000+ scientists for meaningful interaction and discussions where world class scientists, and business professionals deliberate their knowledge with young and aspiring scholars.
Dr. Srinubabu GedelaVilla No. 87, Villa Greens
Hyderabad based Serial Entrepreneur Srinubabu’s enterprise Omics International is world’s leading open access scientific journal with over 1000 journals and growing. His current passion is to build his newest acquisition PULSUS – a 30 year Canadian Health Informatics Company as a go to destination of premium scientific content and Pharmacovigilance (Drug Safety) services.
Born and brought up in a village called Allena in Srikakulam district of Andhra Pradesh Srinububabu completed his schooling in his village and shifted to Andhra University after gaining a seat on merit for doing his B.Pharma in 2000. He later did his M.Tech with specialization in Biotechnology in 2006 and was awarded Ph.D for his work on early stage identification of diabetes in 2008.
While doing his research work Srinubabu faced lot of difficulty to gain access to relevant literature as his University Andhra University did not have subscription to majority of scientific journals. To solve his immediate problem, the Gedela used travel by bus to Hyderabad from Visakhapatnam every month, about 400 miles away from his University to access research content.
Hitting the Entrepreneurial Bug
While pursuing his Doctorate at the Andhra University Srinubabu received Young Scientist Award in 2007 from South Korea for his application of mathematical modelling for life sciences under sponsorship from Human Proteome Organisation (HUPO). During the award ceremony, Dr. Srinubabu expressed his problems of literature access. He debated that scholars from developing countries are not able to access literature there was a need for open access journal.
This is where the entrepreneurial bug bit him. He made a humble beginning with support he received from many scholors with the launch of first open access journal called as Journal of Proteomics & Bioinformatics in 2008. He also bought a domain name for 200 rupees, and made a website with help from his few colleagues in Hyderabad and Visakhapatnam and began building his company named as Omics Online Publishing (later changed to Omics International) catering to information in the fields of biology studies. He posted his first article n April 2008 for the Journal of Proteomics & Bioinformatics.
Named as Omics international - a new science, broadly the application of computation to study biology/life sciences; a name relevant to his doctoral education. Started with one journal in 2008, Omics international now runs 1000 journals with support from 50,000 qualified scientists as editorial board members that post 50,000 articles annually in fields of medicine, technology, and engineering.
Besides its free online open journal Omics also established a robust conference division that went on to hold over 3,000 annual events across 40 more countries. He also garnered support from the healthcare industry, which regularly publishes in the company’s journals and attends its conferences, bringing Omics both credibility and the financial resources to grow.
Stint at Stanford University
During his Post Doctorate studies in Stanford University in 2008 on biomarkers for identification of early stage of cancer he mustered further support from his Stanford Alumni that helped him grow his open access journals and also bring on board qualified scientists as editorial board members to meet the industry standards.
After acquiring PULSUS around the year 2016 - a 30 years old company and well established brand in America, we acquired the company and all acquired journals are running under Pulsus. Srinubabu is keen to strengthen its position in the market as a go-to-destination for premium research articles and healthcare information. The founding company in the mean time grew to 3000 employees having established its operations in Hyderabad, Chennai and in New Delhi.
Srinubabu’ immediate center of attention is to grow PULSUS – into a leading online Health informatics with a sharp focus on Pharmacovigilance services providers. Pulsus will open its centre in SEZ Chennai and thereafter in Gurugram. It aims to grow to a 1000 employee company in the next couple of years from its current level of 500 people working in Hyderabad.
In Hyderabad, headquarters and his newest passion PULSUS are spread over 250,000 square feet in the Special Economic Zone buildings located in the Technology Hub. More than two-thirds among the 3000 people employed by Pulsus and Omics international are women.
By 2020 Srinubabu is planning to expand his employee base to 5,000 at upcoming one million square feet Omics international SEZ campus, Hyderabad and another 3,000 employees at Chennnai, Delhi and Visakhapatnam.
Social Inclinations and interests
Srinubabu Gedela owns a private school for 3,500 students in his village and donated money to build canals and a temple. He is also an investor and has made investments in several startups through Indian Angel Networks, Hyderabad Angels and Ney York Equity Forums.